n-methyl-3,4-methylenedioxyamphetamine has been researched along with pituitrin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, AP | 1 |
| Beitia, G; Cenarruzabeitia, E; Cobreros, A; Sainz, L | 1 |
| Cowan, DA; Fallon, JK; Forsling, ML; Hutt, AJ; Kicman, AT; Shah, D; Tilbrook, GS | 1 |
| Hartung, TK; Henry, JA; Parr, MJ; Schofield, E; Short, AI | 1 |
| Budisavljevic, MN; Ploth, DW; Sahn, SA; Stewart, L | 1 |
| Halperin, ML; Hoorn, EJ; Zietse, R | 1 |
| Arra, M; Emanuele, E; Pesenti, S | 1 |
| Caminer, A; Hicks, C; Kassiou, M; Kevin, R; McGregor, IS; Narlawar, R; Ramos, L | 1 |
| Bastos, ML; Carmo, H; Carvalho, F; Dias da Silva, D; Faria, AC; Silva, JP | 1 |
3 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and pituitrin
| Article | Year |
|---|---|
Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ("Ecstasy") abuse.
Topics: Adolescent; Female; Humans; Hyponatremia; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Chloride; Substance-Related Disorders; Vasopressins | 2003 |
Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Diuresis; Extracellular Fluid; Female; Humans; Hyponatremia; Kidney; Male; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Sodium; Vasopressins | 2005 |
Drinking to death: Hyponatraemia induced by synthetic phenethylamines.
Topics: Alcohol Drinking; Alkaloids; Amphetamine; Drinking; Humans; Hyponatremia; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Neurophysins; Phenethylamines; Protein Precursors; Vasopressins | 2020 |
6 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and pituitrin
| Article | Year |
|---|---|
Hyponatraemia, water intoxication and 'ecstasy'.
Topics: Hallucinogens; Humans; Hyponatremia; N-Methyl-3,4-methylenedioxyamphetamine; Vasopressins; Water Intoxication | 1997 |
3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Signaling; Cell Membrane; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Egtazic Acid; Glutathione; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Time Factors; Transaminases; Vasopressins | 1999 |
The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus.
Topics: Adrenergic Uptake Inhibitors; Animals; Hypothalamus; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin; Pituitary Hormones, Posterior; Rats; Rats, Wistar; Serotonin Agents; Vasopressins | 2002 |
Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion.
Topics: Adolescent; Adult; Alcohol Drinking; Amphetamine-Related Disorders; Drinking; Female; Hallucinogens; Humans; Hyponatremia; Male; N-Methyl-3,4-methylenedioxyamphetamine; Retrospective Studies; Vasopressins | 2002 |
Vasopressin and oxytocin as neurohormonal mediators of MDMA (ecstasy) sociosexual behavioural effects.
Topics: Arousal; Emotions; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin; Serotonin; Sexual Behavior; Social Behavior; Vasopressins | 2006 |
Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Hallucinogens; Hormone Antagonists; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin; Pyrrolidines; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Social Behavior; Vasopressins | 2013 |